Chaim Lotan
Professor Chaim Lotan was born in Hadera, Israel in 1952. He completed medical training at the Hebrew University Hadassah Medical School in 1979 and concluded his specialization in Cardiology in 1987. Between 1987-89 he held a Clinical and Research fellowship in Interventional Cardiology and Nuclear Magnetic Resonance in the Cardiovascular Division of the University of Alabama at Birmingham, Alabama, USA.
In 1995 he also founded the Israeli Working Group for Interventional Cardiology and served as its Secretary General for 4 years. In 1996 he was appointed Director of Interventional Cardiology and Cardiac Catheterization in Hadassah Medical Center in Jerusalem and has been largely responsible for its international reputation till today.
Prof. Lotan was appointed as the director of the Heart Institute in Hadassah University Hospital in Ein Kerem, Jerusalem in 2000 (current position) and later was appointed to the David and Rose Orzen Chair in Cardiology at the Hebrew University-Hadassah Faculty of Medicine. In 2009 he received the appointment of Professor of Medicine (Cardiology) from The Hebrew University of Jerusalem Faculty of Medicine.
Prof. Lotan is the chairman of the Ministry of Health Committee for Certification & Licensing of Coronary Stents in the Israel and has been in addition the principle investigator in many of the leading studies in interventional cardiology and coronary stents, with many publications in this field. He served as President of the Israel Heart Society from May 2011-April 2013. A prominent figure in the world of interventional cardiology, Prof. Lotan has been involved in a number of biomedical innovative ventures and serves as Medical Officer/Advisor in several start-up medical technology companies in the fields of interventional cardiology and cardiac imaging.
Professor Lotan and Professor Rafael Beyar together instigated in 2006 and have since organized annually the scientific meeting "Innovation in Cardiovascular Intervention" (“ICI”), the leading international congress on this important and timely subject.
He has instigated and, together with Dr. Yaakov Nahmias, built the interdisciplinary academic track of Biodesign Innovation at The Hebrew University of Jerusalem in conjunction with the Hadassah Medical Center.
Latest contributions
Artificial intelligence in the cathlab
22 May 2025 – From EuroPCR 2025
Delve into the transformative role of artificial intelligence (AI) in the cathlab. This session covers AI applications for vulnerable plaque identification using intracoronary OCT, automated coronary angiogram analysis, rapid AI-based OCT interpretation, AI-enhanced decision-making for PCI optimization, and noninvasive microvascular resistance assessment powered by AI.
Optimal acute heart failure care: must have, must do
22 May 2025 – From EuroPCR 2025
This session presents must-have strategies for optimal acute heart failure care. Topics include establishing an extracorporeal cardiopulmonary resuscitation referral center with patient outcomes, percutaneous closure in ventricular septal rupture, modified manual compression for large-bore sheaths, antithrombotic therapy considerations in AMI complicated by cardiogenic shock with mechanical...
Degeneration of TAVI valves: a new target for innovations
19 May 2025 – From EuroPCR 2025
Discover the latest innovations targeting degeneration of TAVI valves, including expert presentations and cutting-edge technologies like The Splitter, an enabler for transcatheter aortic valve-in-valve implantation.
Antiplatelet de-escalation after complex PCI: when and how?
15 May 2024 – From EuroPCR 2024
PCI: from basics to robots
14 May 2024 – From EuroPCR 2024
This session covers a wide range of topics in percutaneous coronary intervention (PCI), from fundamental aspects to the latest advancements. It includes discussions on non-fasting versus fasting before interventional procedures, radial artery puncture hemostasis, ultrasound-guided transfemoral puncture in complex PCI, the use of uninterrupted direct-acting oral...
Innovating techniques for the treatment of coronary artery disease
14 May 2024 – From EuroPCR 2024
This session showcases innovative techniques for the treatment of coronary artery disease, including minimum contrast PCI with guide extension catheter and IVUS co-registration, management of iatrogenic aortic dissection using 3D-hologram and computational fluid dynamics, a novel tunnelling technique for huge coronary bypass graft aneurysms, and a...
Embolic protection, TAVI, heart failure and artificial intelligence: what's new in 2023
19 May 2023 – From EuroPCR 2023
This session covers various topics related to transcatheter aortic valve replacement, including the Protect Head-to-Head study on full-body embolic protection during TAVR, the FLOWer device for complete embolic protection, the use of a pulsing aspiration pump for percutaneous thrombectomy, and many more innovation updates from 2023.
Interventions on Pulmonary Embolism: The Next Big Thing?
15 May 2023 – From PCR Innovators Day 2023
Feedback from Innovator's Exchange Hub
15 May 2023 – From PCR Innovators Day 2023
TAVI: Late-Breaking Trials and Innovations
27 Nov 2022 – From PCR London Valves 2022
Consult this session to discover a selection of PCR London Valves 2022 Late-Breaking Trial submissions, and learn more about the early safety and performance of the Vienna TAVI system, the new-generation transcatheter aortic valve platforms performance in native pure aortic regurgitation, and more!
Various indications for closure devices
19 May 2022 – From EuroPCR 2022
Discover various scenarios describing the use of closure devices, such as a percutaneous closure of a broken heart, a transseptal complication, or even a percutaneous closure of ruptured sinus of valsalva aneurysm with a VSD device.
PCR Innovators Day - Jon DeHaan Award winner announcement
19 May 2022 – From EuroPCR 2022
After a look back at the winners of previous editions, find out who the finalists are for 2022 before the suspense is lifted and the winners are finally revealed.
PCR Innovators Day - Follow-up and technology updates
19 May 2022 – From EuroPCR 2022
In this EuroPCR 2022 session, find out more about how mastering heart failure treatment by empowering physicians and patients, discover a novel approach for fluid removal, an adjustable interatrial shunt system, and much more!
PCR Innovators Day - Competition for the Jon DeHaan Award
19 May 2022 – From EuroPCR 2022
Best-graded contributions for the Innovators Day were considered for this competition. Among them, find out more about transcatheter calcium modifying treatment of the stenotic aortic valve, capture technology for treating mitral regurgitation, or transcatheter microwave renal denervation guided by aorticorenal ganglion pacing.
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary stenting: SORT OUT VIII, ROLEX, FANTOM II, and more!
18 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary stenting! FANTOM II trial, five-year follow-up in the SORT OUT VIII trial, impact of side branch disease pattern on outcome following left main PCI, intravascular imaging vs. angiography-guided PCI in high bleeding risk patients, safety and...
EuroPCR 2022 Hotlines / Late-Breaking Trials in coronary artery disease: MASTER DAPT, CRUZ-HBR, DISCO RADIAL, and more!
17 May 2022 – From EuroPCR 2022
Find out more about various studies & registries in coronary artery disease! Abbreviated DAPT after complex PCI in high bleeding risk patients, comparing conventional and haemostatic dressings in radial access, angio-based QFR virtual PCI vs. conventional angio-guided PCI, CRUZ-HBR, CT-guided invasive coronary angiography in patients with...
New innovative solutions for serious needs: check it out!
28 Aug 2019 – From EuroPCR 2019
Consult this session to discover new innovative solutions for serious needs, such as the Ultraseal device, the V-LAP system, and more!
What's new in hypertension treatment – An update for interventionists
23 May 2019 – From EuroPCR 2019
Consult this session to discover the updates in hypertension treatment: learn about new devices for hypertension management, how to apply the new hypertension guidelines in clinical practice, and more!
Transcatheter left atrial decompression for chronic heart failure: evidence, indications and device options
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of left atrial decompression in the multidisciplinary management of chronic heart failure, the device selection, their specifics and how to use them, and more!
Innovative First-in-Man trials and early phase studies
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about innovative First-in-Man trials and early phase studies regarding hypertension, chronic heart failure and renal denervation, such as: TROPHY1, Cryo-RDN, AFR-Prelieve, and more!
Innovations from the ICI 2018 meeting
22 May 2019 – From EuroPCR 2019
Consult this session on innovations from the ICI 2018 meeting to learn more about unmet needs in the cardiovascular field, the importance of medical innovation and discover the outstanding examples of medical innovation presented at the meeting.
Acute/chronic heart failure: new interventional options
21 May 2019 – From EuroPCR 2019
Consult this session on acute/chronic heart failure to discover new interventional options, such as an implantable left-sided pressure sensor for monitoring patients, a cardiac autonomic nerves stimulation to improve haemodynamics and clinical status, the PROPELLA concept, and more!
Presentations by the Jon DeHaan Foundation Grant applicants
20 May 2019 – From PCR Innovators Day 2019